(Q40893169)

English

Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model (English)

1 reference

Europe PubMed Central

24 September 2017

0 references

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

24 September 2017

12

object named as

Califf RM

1 reference

Europe PubMed Central

24 September 2017

Dean J Kereiakes

6

object named as

Kereiakes DJ

1 reference

Europe PubMed Central

24 September 2017

7

object named as

George BS

1 reference

Europe PubMed Central

24 September 2017

Charles W. Abbottsmith

9

object named as

Abbottsmith CW

1 reference

Europe PubMed Central

24 September 2017

author name string

O'Connor CM

1

1 reference

Europe PubMed Central

24 September 2017

Hathaway WR

2

1 reference

Europe PubMed Central

24 September 2017

Bates ER

3

1 reference

Europe PubMed Central

24 September 2017

Leimberger JD

4

1 reference

Europe PubMed Central

24 September 2017

Sigmon KN

5

1 reference

Europe PubMed Central

24 September 2017

Samaha JK

8

1 reference

Europe PubMed Central

24 September 2017

Candela RJ

10

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

24 September 2017

American Heart Journal

1 reference

Europe PubMed Central

24 September 2017

133

1 reference

Europe PubMed Central

24 September 2017

6

1 reference

Europe PubMed Central

24 September 2017

663-673

1 reference

Europe PubMed Central

24 September 2017

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Ba

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Discrepancies between the effects of coronary reperfusion on survival and left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Results of high dose intravenous urokinase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommitte

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Value of partial ejection fraction, volume increment, and regional wall motion in identifying patients with clinically significant coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Variability in the measurement of regional left ventricular wall motion from contrast angiograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Early versus late congestive heart failure after initially uncomplicated anterior wall acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Effects of Thrombolytic Regimen, Early Catheterization, and Predischarge Angiographic Variables on Six-Week Left Ventricular Function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Prognostic significance of posturally induced crackles. Long-term follow-up of patients after recovery from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Factors that influence outcome in diabetic subjects with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Prognosis of patients with diabetes mellitus after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location. The Multicenter Diltiazem Post-Infarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970168-6

7 January 2021

Identifiers

10.1016/S0002-8703(97)70168-6

1 reference

Europe PubMed Central

24 September 2017

release_y47fm67vnnevjliq2f5bpkqlom

1 reference

https://api.fatcat.wiki/v0/release/y47fm67vnnevjliq2f5bpkqlom

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40893169&oldid=1909638238"